News

Unplanned hospitalizations common among elders with gastrointestinal cancers


 

FROM THE JOURNAL OF CLINICAL ONCOLOGY

References

Unplanned hospitalizations are common among older adults with gastrointestinal cancers, especially in the first few months after surgery or chemotherapy.

About 60% experienced at least one unplanned admission, most often for fluid and electrolyte disorders, intestinal obstruction, or pneumonia, Dr. Joanna-Grace M. Manzano and her associates reported (J. Clin. Oncol. 2014 Oct. 6 [doi:10.1200/JCO.2014.55.3131]).

A number of demographic and clinical characteristics increased the risk of such admissions, including black race, low socioeconomic status, dual Medicare/Medicaid eligibility, multiple comorbidities, and advanced disease, said Dr. Manzano of the University of Texas MD Anderson Cancer Center, Houston, and her coauthors. Patients with pancreatic, gastric, and esophageal cancers were especially at risk, they noted.

The team reviewed the medical claims of 30,199 patients older than 66 years who had a diagnosis of gastrointestinal cancer. The mean observation time was 15 months. Among these, there were 60,837 claims; more than half of those were for unplanned hospitalizations. The mean time to first admission was about 2 months after oncologic treatment.

Of those who had such a hospitalization, 19% had undergone chemotherapy, radiotherapy, or a surgical procedure in the prior 30 days. In addition, 9% had visited an emergency department.

Understanding these risk factors could help clinicians keep a preemptive eye out for problems. “Knowing who is at risk for an unplanned hospitalization also opens up opportunities for

anticipatory guidance and patient education during the active phase of treatment,” the investigators wrote.

The authors had no financial disclosures.

msullivan@frontlinemedcom.com

On Twitter @alz_gal

Recommended Reading

VIDEO: Systematic review: Anti-TNFs for IBD don’t up pediatric lymphoma risk
MDedge Hematology and Oncology
Surveillance questioned after low-risk colorectal adenoma removal
MDedge Hematology and Oncology
Majority of cancer patients with depression untreated; integrated collaborative care found ‘strikingly’ effective
MDedge Hematology and Oncology
MicroRNA test improved preop pancreatic cancer diagnosis
MDedge Hematology and Oncology
Postoperative complications increase risk of death in CRC patients
MDedge Hematology and Oncology
Transanal extraction found effective in rectal cancer surgery
MDedge Hematology and Oncology
Laparoscopic resection improved short-term outcomes in patients with cirrhotic liver cancer
MDedge Hematology and Oncology
Radiotherapy suffices for palliation in esophageal cancer
MDedge Hematology and Oncology
New drug boosts survival in metastatic CRC
MDedge Hematology and Oncology
VIDEO: New drug shows efficacy in metastatic CRC
MDedge Hematology and Oncology